17 alpha-hydroxyprogesterone caproate has been researched along with norgestrel in 4 studies
Studies (17 alpha-hydroxyprogesterone caproate) | Trials (17 alpha-hydroxyprogesterone caproate) | Recent Studies (post-2010) (17 alpha-hydroxyprogesterone caproate) | Studies (norgestrel) | Trials (norgestrel) | Recent Studies (post-2010) (norgestrel) |
---|---|---|---|---|---|
517 | 88 | 251 | 2,311 | 492 | 104 |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 4 (100.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Rodriguez, L; Schindler, C | 1 |
Pavlovich, T; Schindler, C | 1 |
Schindler, C | 1 |
Schindler, C; Schober, J | 1 |
4 other study(ies) available for 17 alpha-hydroxyprogesterone caproate and norgestrel
Article | Year |
---|---|
[Comparative studies of the effect on the in vitro growth of endometrial cancers of hydroxyprogesterone caproate, norethisterone acetate and D-norgestrel].
Topics: 17 alpha-Hydroxyprogesterone Caproate; Cells, Cultured; Drug Evaluation, Preclinical; Drug Resistance; Female; Humans; Hydroxyprogesterones; Norethindrone; Norethindrone Acetate; Norgestrel; Uterine Neoplasms | 1984 |
[Comparison of the results of gestagen therapy of cancer of the corpus uteri with a preliminary study of tumor cell culture sensitivity to the preparations].
Topics: 17 alpha-Hydroxyprogesterone Caproate; Cells, Cultured; Drug Evaluation; Drug Evaluation, Preclinical; Drug Resistance; Female; Humans; Hydroxyprogesterones; Norethindrone; Norgestrel; Progesterone Congeners; Uterine Neoplasms | 1982 |
[Use of gestagens to control in vitro growth of endometrial carcinoma (author's transl)].
Topics: 17 alpha-Hydroxyprogesterone Caproate; Cells, Cultured; Drug Resistance; Female; Humans; Hydroxyprogesterones; Norethindrone; Norgestrel; Progestins; Uterine Neoplasms | 1981 |
[Results obtained from gestagen treatment of patients for endometrial carcinoma, with particular reference to results obtained from in vitro tests before treatment (author's transl)].
Topics: 17 alpha-Hydroxyprogesterone Caproate; Drug Resistance; Female; Humans; Hydroxyprogesterones; Neoplasm Staging; Norethindrone; Norethindrone Acetate; Norgestrel; Uterine Neoplasms | 1981 |